Lyka Labs Limited (LYKALABS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.135x

Based on the latest financial reports, Lyka Labs Limited (LYKALABS) has a cash flow conversion efficiency ratio of 0.135x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs136.84 Million ≈ $1.48 Million USD) by net assets (Rs1.01 Billion ≈ $10.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See LYKALABS defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Lyka Labs Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Lyka Labs Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lyka Labs Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lyka Labs Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hulamin JSE:HLM	0.009x
East Asia Holdings Investment Limited KQ:900110	0.031x
Triniti Dinamik PT Tbk JK:TRUE	0.022x
Advance NanoTek Limited F:BBJ	0.047x
Comms Group Ltd AU:CCG	0.068x
Barinthus Biotherapeutics plc NASDAQ:BRNS	-0.127x
KCP Sugar and Industries Corporation Limited NSE:KCPSUGIND	0.087x
Utron Ltd TA:UTRN	0.127x

Annual Cash Flow Conversion Efficiency for Lyka Labs Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Lyka Labs Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Lyka Labs Limited market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs1.04 Billion ≈ $11.20 Million	Rs18.99 Million ≈ $205.41K	0.018x	-29.41%
2024-03-31	Rs682.65 Million ≈ $7.38 Million	Rs17.73 Million ≈ $191.78K	0.026x	-86.75%
2023-03-31	Rs456.71 Million ≈ $4.94 Million	Rs89.53 Million ≈ $968.19K	0.196x	-96.66%
2022-03-31	Rs134.91 Million ≈ $1.46 Million	Rs792.46 Million ≈ $8.57 Million	5.874x	+1772.76%
2021-03-31	Rs-250.93 Million ≈ $-2.71 Million	Rs88.11 Million ≈ $952.93K	-0.351x	+0.32%
2020-03-31	Rs-151.11 Million ≈ $-1.63 Million	Rs53.23 Million ≈ $575.71K	-0.352x	-160.45%
2019-03-31	Rs457.59 Million ≈ $4.95 Million	Rs266.66 Million ≈ $2.88 Million	0.583x	+211.82%
2018-03-31	Rs582.36 Million ≈ $6.30 Million	Rs108.83 Million ≈ $1.18 Million	0.187x	-74.93%
2017-03-31	Rs421.01 Million ≈ $4.55 Million	Rs313.81 Million ≈ $3.39 Million	0.745x	+1938.60%
2016-03-31	Rs491.54 Million ≈ $5.32 Million	Rs-19.93 Million ≈ $-215.50K	-0.041x	-107.11%
2015-03-31	Rs465.71 Million ≈ $5.04 Million	Rs265.40 Million ≈ $2.87 Million	0.570x	-64.17%
2014-03-31	Rs560.17 Million ≈ $6.06 Million	Rs890.99 Million ≈ $9.64 Million	1.591x	+914.04%
2013-03-31	Rs697.62 Million ≈ $7.54 Million	Rs109.43 Million ≈ $1.18 Million	0.157x	+154.43%
2012-03-31	Rs755.73 Million ≈ $8.17 Million	Rs-217.78 Million ≈ $-2.36 Million	-0.288x	-380.89%
2010-03-31	Rs1.43 Billion ≈ $15.41 Million	Rs146.23 Million ≈ $1.58 Million	0.103x	+129.68%
2008-03-31	Rs780.73 Million ≈ $8.44 Million	Rs-269.87 Million ≈ $-2.92 Million	-0.346x	-33.00%
2007-03-31	Rs460.74 Million ≈ $4.98 Million	Rs-119.75 Million ≈ $-1.29 Million	-0.260x	-136.00%
2005-03-31	Rs286.25 Million ≈ $3.10 Million	Rs206.68 Million ≈ $2.24 Million	0.722x	--

About Lyka Labs Limited

NSE:LYKALABS India Biotechnology

Market Cap

$27.04 Million

Rs2.50 Billion INR

Market Cap Rank

#24155 Global

#1331 in India

Share Price

Rs70.06

Change (1 day)

-0.64%

52-Week Range

Rs44.95 - Rs116.18

All Time High

Rs254.30